SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,339,000 | -23.9% | 121,504 | -8.4% | 0.25% | -17.2% |
| Q2 2019 | $4,388,000 | -15.9% | 132,607 | -11.0% | 0.30% | -8.7% |
| Q1 2019 | $5,220,000 | +7.1% | 148,974 | +1.5% | 0.33% | -5.4% |
| Q4 2018 | $4,875,000 | -40.9% | 146,739 | -10.5% | 0.35% | -23.0% |
| Q3 2018 | $8,255,000 | -23.9% | 163,956 | -9.6% | 0.46% | -25.9% |
| Q2 2018 | $10,850,000 | +18.4% | 181,283 | -9.4% | 0.62% | +21.1% |
| Q1 2018 | $9,162,000 | -11.8% | 200,042 | -23.3% | 0.51% | +2.4% |
| Q4 2017 | $10,388,000 | +48.8% | 260,676 | +49.3% | 0.50% | +74.6% |
| Q3 2017 | $6,983,000 | – | 174,572 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |